Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse

Frontiers in Neurology - Switzerland
doi 10.3389/fneur.2019.00460
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Frontiers Media SA

Related search

Evaluation of Early Imaging Response Criteria in Glioblastoma Multiforme

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2016English

Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2012English

Efficacy and Safety of Bevacizumab for the Treatment of Glioblastoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Update and Developments in the Treatment of Glioblastoma Multiforme &Ndash; Focus on Bevacizumab

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2010English

Czech Suburbanization in Post-Transformation Era – The Development, Evaluation and Challenges

2019English

Czech Suburbanization in Post-Transformation Era – The Development, Evaluation and Challenges

2019English

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy €“ Detecting Illusive Disease, Defining Response

Frontiers in Neurology
Neurology
2015English

Sustained Focal Antitumor Activity of Bevacizumab in Recurrent Glioblastoma

Neurology
Neurology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy